Jonathan Knight is an intellectual property counsel with extensive patent and non-patent litigation and counseling experience. In particular, his patent litigation practice comprises appellate, district court, and ITC cases, including litigation of invalidity and non-infringement positions, analysis of accused products and technical documents, and steering technical expert and source code discovery. He also represents parties in inter partes review proceedings before the Patent Trial and Appeal Board, engaging in all phases of IPR trials, including oral arguments, development of petitions and responses, discovery, RPI briefing and rehearing/POP practice. His work in both litigation and post-grant practice has spanned a broad range of technology fields, including thermal analysis of derailed train cars, polymer chemistry, wind turbine technology, Wi-Fi, content delivery networks, video encoding, video streaming, mobile check deposit systems and light therapy technology.

His patent counseling practice includes intellectual property advice to professional services firms regarding use cases for generative artificial intelligence.  His practice also builds upon his prior experience as a research chemical engineer and finance professional, helping clients procure and exploit proprietary patent positions in artificial intelligence, FinTech, and chemical technologies. His clients have included leading-edge firms focused in artificial intelligence, banking, cybersecurity, blockchain, internet-of-things, pharma, immunoassays, digital health, medical devices, firearm safety and green technology.

His practice includes domestic and international patent procurement, noninfringement opinions, patent validity opinions, IP due diligence, licensing (including analysis of software GPL issues) and business counseling.

Before entering the legal profession, Dr. Knight worked in finance developing proprietary valuation technology for leveraged mortgage arbitrage, heading a team of five PhDs and more than a dozen software, database and network professionals. Dr. Knight founded a firm that deployed capital in asset-backed structured finance (ABS), asset-based loans (ABLs) and private investments in public companies (PIPEs).

Dr. Knight's doctoral thesis integrated computational chemistry tools in mathematical programming-guided design of chemical processes. As a research engineer, he developed a test reactor cooperatively configured with process simulation tools to assess scalability of cationic polymerization catalysts.

Experience

  • PROFESSIONAL ACTIVITIES

    • Chair, Ex Parte Pro Bono Committee, PTAB Bar Association (2024)
  • PTAB PROCEEDINGS

    • Bombardier Inc. v. The Litebook Company Ltd., IPR2023-00192 (US 7,678,140) (Light therapy technology)
    • General Electric Company et al v. Siemens Gamesa Renewable Energy A/S, IPR2021-00722 challenging (US 9,279,413) (Offshore wind turbine technology)
    • Lenovo (United States) Inc. v. Nokia Technologies Oy, IPR2020-01096 (US 7,263,125) (H.264-related)
    • PNC Bank, NA v. United Services Automobile Association, IPRs 2021-01070 (US 8,699,779), 2021-01073 (US 8,977,571), and 2022-00076 (US 10,769,598) (Mobile check capture technologies)
    • Unified Patents, LLC v. Dolby Laboratories Licensing Corporation, IPR2022-01508 (US 11,176,711) (Video compression technology)
    • Unified Patents, LLC v. Ideahub, Inc., IPR2020-01338 (US 8,645,562) (Adaptive streaming technology)
    • Unified Patents, LLC v. Velos Media, LLC, IPRs 2019-00194 (US 9,338,449), 2019-00635 (US 8,767,824), 2019-00707 (US 9,979,981), 2019-00710 (8,964,849) (Video compression technologies)
  • LITIGATION

    • Align Technology, Inc. v. ClearCorrect Operating, LLC et al.; 6:24-cv-00187 (WDTX) involving U.S. Patent Nos. U.S. Patent Nos. 10,973,613, 11,154,384, 11,648,090, 11,648,091, 8,038,444, 10,456,217, 10,524,879, 11,369,456 and 10,791,936 (orthodontic aligner materials, treatment planning, and scanning)

    • Feezle et al v. Norfolk Southern Railway Co. et al; 4:23-cv-0242 (NDOH) relating to East Palestine train derailment (Wayside detection and bearing failure, removal options for hazardous materials, pressure relief devices, monomer chemistry, thermal analysis, and safety data sheets)

    • The Litebook Company Ltd. v. Bombardier Aerospace Corporation et al; 4:22-cv-00615 (NDTX) involving U.S. Patent No. 7,678,140 (Light therapy technology)
    • Siemens Gamesa Renewable Energy A/S v. General Electric Co.; 1:21-cv-10216 (DMA) involving U.S. Patent Nos. 9,279,413 and 8,575,776 (Wind turbine-related patents)
    • United Services Automobile Association v. PNC Bank N.A.; 2:21-cv-00246 (EDTX) involving U.S. Patent Nos. 10,402,638, 10,769,598, and 9,224,136 (Bank-related patents)
    • United Services Automobile Association v. BBVA USA; 2:21-cv-00311 (EDTX) involving U.S. Patent Nos. 10,482,432, 10,621,559, 8,699,779, 8,977,571, 10,013,605, and 10,013,681 (Bank-related patents)
    • Certain Electronic Devices, Including Computers, Tablet Computers, and Components and Modules Thereof; Investigation No. 337-TA-1208 involving U.S. Patent Nos. 8,144,764, 7,532,808, 6,950,469, and 7,724,818 (H.264-related patents)

Recognition

  • Selected for inclusion in Best Lawyers: Ones to Watch for his intellectual property law practice (2023–2025) and intellectual property litigation (2025)

Insights & News

Credentials

  • Education

    • JD, George Washington University Law School, 2015

      With honors
    • PhD, Chemical Engineering, Massachusetts Institute of Technology, 1995

    • BS, Chemical Engineering, Florida Institute of Technology, 1990

  • Admissions

    • District of Columbia

    • US Patent and Trademark Office

Credentials

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.